Balyasny Asset Management
AEON.WS

Balyasny Asset Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Balyasny Asset Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-66,666
Closed -$4.37K – 3009
2023
Q1 		$4.37K Hold
66,666
– – ﹤0.01% 2553
2022
Q4 		$3.04K Hold
66,666
– – ﹤0.01% 2656
2022
Q3 		$5K Hold
66,666
– – ﹤0.01% 2714
2022
Q2 		$10K Hold
66,666
– – ﹤0.01% 2585
2022
Q1 		$21K Hold
66,666
– – ﹤0.01% 2348
2021
Q4 		$34K Hold
66,666
– – ﹤0.01% 2114
2021
Q3 		$37K Hold
66,666
– – ﹤0.01% 1816
2021
Q2 		$67K Buy
+66,666
New +$50.6K ﹤0.01% 1831

Other funds holding AEON.WS

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Balyasny Asset Management's AEON.WS Position: Q2 2023 in Review

Balyasny Asset Management sold out of AEON Biopharma Inc (AEON.WS) in Q2 2023, closing a stake of 66,666 shares — an estimated $4.37K sold.

Balyasny Asset Management first reported a position in AEON.WS in Q2 2021 and held it in 8 quarters. The position peaked at $67K in Q2 2021. 42 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2023.

  • Balyasny Asset Management reported no remaining AEON Biopharma Inc position as of Q2 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 66,666 AEON Biopharma Inc shares in Q2 2023, an estimated $4.37K.
  • Balyasny Asset Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 8 quarters.
  • Balyasny Asset Management's AEON Biopharma Inc position peaked at $67K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.